Iran is a large pharmaceutical market in regional terms having a large and fast-growing population of more than 70 million and wide public healthcare coverage. Although Iran has low per capita pharmaceutical consumption (around US$34.7 in 2008 and 40.0 US$ in 2009) compared to other countries in the region, the large size of its population […]
Iran is trying to grow its pharmaceutical exports and attract investment. But on the other hand, an increase in output could potentially have a detrimental effect on the price and availability of certain medicines. To strengthen the industry, Iran has been turning to other countries and foreign companies for investment. In the six months since […]